LMR Partners LLP Cuts Stock Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

LMR Partners LLP decreased its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 69.6% in the third quarter, HoldingsChannel reports. The fund owned 10,000 shares of the company’s stock after selling 22,938 shares during the quarter. LMR Partners LLP’s holdings in Establishment Labs were worth $433,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Hood River Capital Management LLC purchased a new stake in shares of Establishment Labs during the 2nd quarter valued at $43,000. Nkcfo LLC acquired a new stake in Establishment Labs in the second quarter worth about $227,000. SG Americas Securities LLC purchased a new stake in shares of Establishment Labs during the second quarter worth about $303,000. Black Swift Group LLC acquired a new position in shares of Establishment Labs during the third quarter valued at about $312,000. Finally, Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new position in shares of Establishment Labs in the 2nd quarter valued at approximately $373,000. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. BTIG Research upped their price target on shares of Establishment Labs from $62.00 to $65.00 and gave the company a “buy” rating in a research note on Monday, October 14th. JPMorgan Chase & Co. cut their target price on Establishment Labs from $61.00 to $50.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 7th. Citigroup lifted their price target on Establishment Labs from $45.00 to $50.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 1st. Finally, Stephens reissued an “overweight” rating and issued a $68.00 price objective on shares of Establishment Labs in a report on Wednesday, August 7th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, Establishment Labs has an average rating of “Moderate Buy” and a consensus target price of $60.60.

Establishment Labs Trading Down 0.7 %

Shares of Establishment Labs stock opened at $37.52 on Wednesday. Establishment Labs Holdings Inc. has a 1 year low of $21.25 and a 1 year high of $60.12. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. The stock has a market cap of $1.05 billion, a PE ratio of -14.52 and a beta of 1.20. The firm has a fifty day moving average price of $43.06 and a 200 day moving average price of $45.46.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.